- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/245 - Escherichia (G)
Patent holdings for IPC class C07K 14/245
Total number of patents in this class: 1176
10-year publication summary
|
80
|
79
|
85
|
85
|
74
|
81
|
95
|
78
|
93
|
72
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| CJ Cheiljedang Corporation | 3474 |
57 |
| Synlogic Operating Company, Inc. | 115 |
31 |
| Ajinomoto Co., Inc. | 2306 |
23 |
| Glaxosmithkline Biologicals S.A. | 1653 |
22 |
| Oxford NanoPore Technologies plc | 351 |
19 |
| President and Fellows of Harvard College | 6028 |
18 |
| The Regents of the University of California | 20245 |
16 |
| Molecular Templates, Inc. | 69 |
16 |
| Inbiose naamloze vennootschap | 142 |
16 |
| Vib VZW | 883 |
14 |
| Vrije Universiteit Brussel | 513 |
14 |
| Massachusetts Institute of Technology | 10124 |
12 |
| BASF SE | 21083 |
10 |
| Pfizer Inc. | 3403 |
10 |
| The Johns Hopkins University | 5746 |
10 |
| Daesang Corporation | 339 |
10 |
| UCB Pharma S.A. | 239 |
10 |
| University of Massachusetts | 2256 |
10 |
| Janssen Pharmaceuticals, Inc. | 441 |
9 |
| Centre National de La Recherche Scientifique | 10645 |
9 |
| Other owners | 840 |